Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002.

Fenton, Kevin A; Ison, Catherine; Johnson, Alan P; Rudd, Elizabeth; Soltani, Mehnam; Martin, Iona; Nichols, Tom; Livermore, David M

Fenton, Kevin A; Ison, Catherine; Johnson, Alan P; Rudd, Elizabeth; Soltani, Mehnam; Martin, Iona; Nichols, Tom; Livermore, David M.

Affiliation

Fenton KA; Communicable Disease Surveillance Centre, Health Protection Agency, London, UK. kevin.fenton@hpa.org.uk <kevin.fenton@hpa.org.uk>

Lancet ; 361(9372): 1867-9, 2003 May 31.

Article in En | MEDLINE | ID: mdl-12788575

Subject(s)

Anti-Infective Agents/pharmacology; Ciprofloxacin/pharmacology; Gonorrhea/microbiology; Neisseria gonorrhoeae/drug effects; Drug Resistance, Bacterial; England/epidemiology; Female; Gonorrhea/epidemiology; Humans; Male; Microbial Sensitivity Tests; Population Surveillance; Wales/epidemiology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ciprofloxacin / Gonorrhea / Anti-Infective Agents / Neisseria gonorrhoeae Type of study: Guideline / Risk_factors_studies / Screening_studies Limits: Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Lancet Year: 2003 Document type: Article Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links